21 May 2009
Ann Transplant 2009; 14(1): 18-19 :: ID: 880263
The use of a live donor as a source for organs for transplantation is a unique act in medicine. With very few exceptions, the basis for medical treatment is the benefit for the individual patient. However, in the case of a live donor, we actually harm - or at least potentially harm - a healthy individual for the benefit of someone else. A free and truly informed consent is the basis for live donation. The potential donor must be capable of understanding the information given and the decision to donate should be voluntary and without coercion. The Amsterdam and Vancouver Fora on live donation establish the responsibility of the transplant team to perform complete medical and psychosocial evaluation and to care for the donor during post-operative recovery. There is also the responsibility to facilitate long-term follow-up and treatment and to identify and track complication. It is recommended that the donor should be evaluated by a different team than the one caring for the recipient. The scarcity of organs is a worldwide problem. No country has a true excess. Still, a global trade in organs has developed with transplant tourism and even trafficking of donors and organs. WHO has estimated that 50,000 kidneys are transplanted yearly worldwide. 20,000 of them are from live donors and the number of trafficked organs is estimated to be between 5,000 and 8,000 per year. A number of scientific gropus have performed psychosocial evaluation of paid donors and the results in Iran, Pakistan and the Philippines are similar. A majority of the donors regret donation and they feel that they have not recovered fully. In the absolute majority of cases, the economical situation one year after donation has not improved. It is important that all countries with transplantation activities have a regulatory framework for live and deceased donation. To lessen the burden on live donors it is likewise important to establish and promote deceased donation globally.
06 May 2022 : Original articlePhosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...
Ann Transplant In Press; DOI: 10.12659/AOT.936293
Most Viewed Current Articles
31 Dec 1969 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
31 Dec 1969 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
31 Dec 1969 : Review articleKidney Transplantation in the Times of COVID-19 – A Literature Review
Ann Transplant 2020; 25:e925755